Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Sweden Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20052
20061
20073
20081
20092
20112
20122
20133
20141
20152
20182
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Boehringer Ingelheim3
Bayer2
Novo Nordisk A/S2
Alizyme1
Amgen1
Anders Rosengren, MD PhD1
Claes-Göran Östenson1
Diamyd Therapeutics AB1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 227
Diabetes Mellitus4
Obesity4
Diabetic Nephropathies2
Heart Failure2
Overweight2
Renal Insufficiency, Chronic2
Autoimmune Diseases1
Body Weight1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.